OPKO Health (OPK) – PRNewswire
-
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
-
NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st
-
NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China
-
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
-
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
-
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
-
GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions
-
Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease
-
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
-
GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes
-
Sports Tech Company, Orreco and Scarlet Health team up to provide a new solution for Athletes to optimize performance
-
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
-
BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry
-
Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year
-
BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball
-
BioReference Laboratories Expands COVID-19 School Testing Program
-
New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy
-
OPKO Health's GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia
-
OPKO Health's BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing
-
OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access
-
OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide
-
Buffalo Bills and OPKO Health's BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program
-
OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test
-
OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools
-
Notice of Class Action Settlement Involving Purchasers of OPKO Health, Inc. Common Stock during the period of September 26, 2013 through September 7, 2018
-
OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program
-
OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay
-
OPKO Health's GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services
-
OPKO Health's GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio
-
OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)
-
OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees
-
Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees
-
OPKO Health's BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home and Live-in Facility Employees
-
MagnaCare and BioReference Laboratories Bring COVID-19 Antibody Testing to New York Labor Groups
-
OPKO Health's BioReference Laboratories Launches COVID-19 Employer Solution
-
OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network Enter Into Strategic Laboratory Collaboration to Deliver Operational and Diagnostic Services
-
OPKO Health's BioReference Laboratories Launches COVID-19 Antibody Screening for New York City Residents
-
OPKO Health's BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies
-
OPKO Health's BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19)
-
OPKO Health's BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)
-
OPKO Health's BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)
-
OPKO Health's BioReference Laboratories and State of New Jersey Provide Testing for Coronavirus Disease 2019 (COVID-19)
-
OPKO Health's BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19)
-
OPKO's BioReference Laboratories Offers Testing for Coronavirus Disease 2019 (COVID-19)
-
OPKO Health's BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test
Back to OPK Stock Lookup
